Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion

References

• Chang TMS. 2007. Monograph on artificial cells: biotechnology, nanotechnology, blood substitutes, regenerative medicine, bioencapsulation. Singapore/London: World Science Publisher/Imperial College Press.
   Google Scholar
• Chang TMS. Nanobiotechnology for haemoglobin-based blood substitutes. Crit Care Clin. 2009;25:373–382.
   PubMed Web of Science ®Google Scholar
• Chang TMS. From artificial red blood cells, oxygen carriers. Artif Cells Blood Immobil Substit Biotechnol. 2012;40:197–199.
   PubMed Web of Science ®Google Scholar
• Chang TMS. Translational feasibility of soluble nanobiotherapeutics with enhanced red blood cell functions. Artif Cells Nanomed Biotechnol. 2017;45:671–676.
   PubMed Web of Science ®Google Scholar
• Kim HW, Greenburg AG. Hemoglobin-based oxygen carriers as red cell substitutes and oxygen therapeutics. New York: Springer; 2014.
   Google Scholar
• Mer M, Hodgson E, Wallis L, et al. Hemoglobin glutamer-250 (bovine) in South Africa: consensus usage guidelines from clinician experts who have treated patients. Transfusion 2016;56:2631–2636.
   PubMed Web of Science ®Google Scholar
• Weiskopf RB, , Beliaev AM, Shander A, et al. Addressing the unmet need of life-threatening anemia with hemoglobin-based oxygen carriers. Transfusion. 2017;57:207–214.
   PubMed Web of Science ®Google Scholar
• Chang TMS. Semipermeable microcapsules. Science. 1964;146:524–525.
   PubMed Web of Science ®Google Scholar
• Chang TMS. Stabilisation of enzymes by microencapsulation with a concentrated protein solution or by cross-linking with glutaraldehyde. Biochem Biophys Res Commun. 1971;44:1531–1533.
   PubMed Web of Science ®Google Scholar
• Jahr JS, Mackenzie C, Pearce LB, et al. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma. 2008;64:1484–1497.
   PubMed Web of Science ®Google Scholar
• Moore EE, Moore FA, Fabian TC, et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009;208:1–13.
   PubMed Web of Science ®Google Scholar
• Weiskopf RB, Silverman TA. Balancing potential risks and benefits of hemoglobin-based oxygen carriers. Transfusion. 2013;53:2327–2333.
   PubMed Web of Science ®Google Scholar
• D'Agnillo F, Chang TM Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties. Nat Biotechnol. 1998;16:667–671.
   PubMed Web of Science ®Google Scholar
• Powanda DD, Chang TM. Cross-linked polyhemoglobin-superoxide dismutase-catalase supplies oxygen without causing blood-brain barrier disruption or brain edema in a rat model of transient global brain ischemia-reperfusion. Art Cells Blood Subs and Immob Biotech. 2001;30:23–37.
   Google Scholar
• Alayash AI. Redox biology of blood. Antioxid Redox Signal. 2004;6:941–943.
   PubMed Web of Science ®Google Scholar
• Alayash AI, D'Agnillo F, Buehler PW. First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives. Expert Opin Biol Ther. 2007;7:665–675.
   PubMed Web of Science ®Google Scholar
• Buehler PW, Haney CR, Gulati A, et al. Polynitroxyl hemoglobin: a pharmacokinetic study of covalently bound nitroxides to hemoglobin platforms. Free Radic Biol Med. 2004;37:124–135.
   PubMed Web of Science ®Google Scholar
• Ma L, Hsia CJ. Polynitroxylated hemoglobin as a multifunctional therapeutic for critical care and transfusion medicine. In: Chang TMS. Selected topics in nanomedicine. Singapore: World Science Publisher and Imperial College Press; 2013.
   Google Scholar
• Sims C, Seigne P, Menconi M, et al. Skeletal muscle acidosis correlates with the severity of blood volume loss during shock and resuscitation. J Trauma. 2001;51:1137–1145.
   PubMed Web of Science ®Google Scholar
• Bian Y, Rong Z, Chang TMS. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant. Artifi Cells Blood Substit Biotechnol. 2011;39:127–136.
   PubMed Web of Science ®Google Scholar
• Bian Y, Chang TMS. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume. Artifi Cells Nanomed Biotechnol. 2015;43:1–9.
   PubMed Web of Science ®Google Scholar
• Bian Y, Gao W, Chang TMS. Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant pro. Artifi Cells Nanomed Biotechnol. 2013;41:60–68.
   PubMed Web of Science ®Google Scholar
• Bian Y, Guo C, Chang TMS. Temperature stability of poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at −80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C. Artif Cells Nanomed Biotechnol. 2016;44:41–47.
   Web of Science ®Google Scholar
• Guo C, Gynn M, Chang TMS. Extraction of superoxide dismutase, catalase, and carbonic anhydrase from stroma-free red blood cell hemolysate for the preparation of the nanobiotechnological complex of polyhemoglobin–superoxide dismutase–catalase–carbonic anhydrase. Artif Cells Nanomed Biotechnol. 2015;43:157–162.
   PubMed Web of Science ®Google Scholar
• Chang TMS. Red blood cell replacement or nanobiotherapeutics with enhanced red blood cell functions? Artif Cells Nanomed Biotechnol. 2015;43:145–147.
   PubMed Web of Science ®Google Scholar
• Bailley GS. Ouchterlony double immunodiffusion. In: Walker JM. The protein protocols handbook. Totowa: Humana Press Inc.; 1996. p. 749–752.
   Google Scholar
• Bajic G, Yatime L, Klos A, et al. Human C3a and C3a desArg anaphylatoxins have conserved structures, in contrast to C5a and C5a desArg. Protein Sci. 2013;22:204–212.
   PubMed Web of Science ®Google Scholar
• Ning J, Chang TMS. Effects of homologous and heterologous stroma-free hemoglobin and polyhemoglobin on blood cell counts, complement activation and coagulation factors in rats. Biomat Artif Cells Artif Organs. 1987;15:380.
   Google Scholar
• Ning J, Chang TMS. Effects of homologous and heterologous stroma-free hemoglobin and polyhemoglobin on complement activation, leucocytes and platelets. Biomat Artif Cells Artif Organs. 1990;18:219–233.
   PubMed Web of Science ®Google Scholar
• Chang TMS. Blood Substitutes: principles, methods, products, and clinical trials. Basel: Karger Landes; 1997.
   Google Scholar
• Amin K. The role of mast cells in allergic inflammation. Respir Med. 2012;106:9–14.
   PubMed Web of Science ®Google Scholar
• Sperr WR, Jordan JH, Fiegl M, et al. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease. Int Arch Allergy Immunol. 2002;128:136–141.
   PubMed Web of Science ®Google Scholar
• Ao-ieong ESY, Alexander W, Jani V, et al. Cardiac function during resuscitation from hemorrhagic shock with polymerized bovine hemoglobin-based oxygen therapeutic. Artif Cells Nanomed Biotechnol. 2017;45:686–693.
   PubMed Web of Science ®Google Scholar
• Arthurs G, Sudhakar M. Carbon dioxide transport. Continuing Education in Anaesthesia. Crit Care Pain. 2005;5:207–210.
   Google Scholar
• Geers C, Gros G. Carbon dioxide transport and carbonic anhydrase in blood and muscle. Physiol Rev. 2000;80:681–715.
   PubMed Web of Science ®Google Scholar
• Jiang W, Bian Y, Wang Z, Chang TMS. Hepatoprotective effects of poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] on alcohol-damaged primary rat hepatocyte culture in vitro. Artif Cells Nanomed Biotechnol. 2016;45:46–50.
   PubMed Web of Science ®Google Scholar
• Liu H, Yan C, Yan K, et al. Study of the effects of polymerized porcine hemoglobin (pPolyHb) in an acute anemia rat model. Artif Cells Nanomed Biotechnol. 2017;4:694–700.
   Google Scholar
• Martucci AF, Martucci AC, Cabrale P, et al. Acute kidney function and morphology following topload administration of recombinant hemoglobin solution. Artif Cells Nanomed Biotechnol. 2017;45:24–30.
   PubMed Web of Science ®Google Scholar
• Terraneo L, Bianciardi P, Malavalli A, et al. Hemoglobin extravasation in the brain of rats exchange-transfused with hemoglobin-based oxygen carriers. Artif Cells Nanomed Biotechnol. 2017;45:710–716.
   PubMed Web of Science ®Google Scholar
• Wang L, Liu F, Yan K, et al. Effects of resuscitation with polymerized porcine hemoglobin (pPolyHb) on hemodynamic stability and oxygen delivery in a rat modelof hemorrhagic shock. Artif Cells Nanomed Biotechnol. 2017;45:51–57.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yan C, Xu L, et al. The effect of pPolyHb on hemodynamic stability and mesenteric microcirculation in a rat model of hemorrhagic shock. Artif Cells Nanomed Biotechnol. 2017;45:677–685.
   PubMed Web of Science ®Google Scholar
• Zhu H, Du Q, Chen C, et al. The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate. Artif Cells Blood Substit Immobil Biotechnol. 2010;38:57–63.
   PubMed Web of Science ®Google Scholar